Eloxx Pharmaceuticals Reports First Quarter 2022 Financial and Operating Results and Provides Business Update
Cystic Fibrosis Foundation awarded up to $15.9 million for the ongoing ELX-02 clinical program Topline data from cystic fibrosis Phase 2 expansion... | May 10, 2022
Source: marketscreener.com